Pneumocystis jirovecii, Quantitative Real‑Time PCR
Use
This real‑time PCR test is intended for the quantitative detection of Pneumocystis jirovecii DNA in clinical specimens, primarily respiratory samples such as bronchoalveolar lavage or bronchial wash. It is used in the diagnosis of Pneumocystis pneumonia, especially in immunocompromised patients. Quantitative results (copies/mL) facilitate distinction between colonization and active infection.
Special Instructions
Not provided.
Limitations
Laboratory test results should always be considered in the context of clinical observations. This test was developed and its performance characteristics determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration (FDA); the FDA has determined that such clearance or approval is not necessary. Use is for clinical purposes and not investigational. CLIA‑certified high complexity testing.
Methodology
PCR-based (PCR)
Biomarkers
Pneumocystis jirovecii
Microorganism
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
1 mL
Minimum Volume
0.5 mL
Container
Sterile, leak‑proof container
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant